Vascular Biogenics Ltd (VBLT)


Stock Price Forecast

Oct. 16, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Vascular Biogenics Ltd chart...

About the Company

vascular biogenics ltd. is a biotechnology company located in 6yonatan netanyahu street, yehud, center district, israel.

CEO

Dror Harats

Exchange

NASDAQ

Website

http://www.vblrx.com

$1M

Total Revenue

17

Employees

$11M

Market Capitalization

-3.49

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VBLT News

Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform

13d ago, source: Business Insider

March 05, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL ... described in the section titled “Risk Factors” in the Registration Statement of Vascular Biogenics Ltd. on Form S-4, as filed ...

BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy

4d ago, source: TMCnet

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved TEVIMBRA ® (tislelizumab-jsgr) as monotherapy for the ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...